Anti-DPH2 Antilichaam

Required for the first step in the synthesis of diphthamide, a post-translational modification of histidine which occurs in translation elongation factor 2 (EEF2) . When overexpressed, suppresses colony formation ability and growth rate of ovarian cancer cells. Mutants of the DPH1, DPH2, and DPH5 (611075) genes, involved in diphthamide biosynthesis, were identified as resistant to both anthrax toxin and diphtheria toxin. This antibody works well in WB, IP, IHC and IF application.

Boster Bio Anti-DPH2 Antibody catalog # A12485-1. Tested in WB, IHC, ICC, IF, IP, ELISA applications. This antibody reacts with Human, Mouse.

S-adenosyl-L-methionine:L-histidine 3-amino-3-carboxypropyltransferase 2; HsDph2; DPH2L2; Diphtheria toxin resistance protein 2; 2- (3-amino-3-carboxypropyl) histidine synthase subunit 2

DPH2

Q9BQC3

Human, Mouse

E.coli-derived human DPH2 recombinant protein (Position: E192-G487) .

WB, IHC, ICC, IF, IP, ELISA

Immunogen affinity purified.

500 μg/mL

Liquid

12 months from date of receipt, -20°C as supplied. 6 months 2 to 8°C after reconstitution. Avoid repeated freezing and thawing.

https://www.bosterbio.com/msds?sku=A12485-1

Diphthamide biosynthesis 2

2- (3-amino-3-carboxypropyl) histidine synthase subunit 2

500 μg/mL antibody with PBS,0.02% NaN3, 1 mg BSA and 50% glycerol.